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In eukaryotes, there are still steps of the vitamin B1 biosynthetic pathway not completely understood. In
Arabidopsis thaliana, THI1 protein has been associatedwith the synthesis of the thiazole ring, a ﬁnding supported
by the identiﬁcation of a thiamine pyrophosphate (TPP)-like compound in its structure. Here, we investigated
THI1 and its mutant THI1(A140V), responsible for the thiamin auxotrophy in a A. thalianamutant line, aiming
to clarify the impact of this mutation in the stability and activity of THI1. Recently, the THI1 orthologue (THI4)
was revealed to be responsible for the donation of the sulfur atom from a cysteine residue to the thiazole
ring in the thiamine intermediate. In this context, we carried out a cysteine quantiﬁcation in THI1 and
THI1(A140V) using electron spin resonance (ESR). These data showed that THI1(A140V) contains more
sulfur-containing cysteines than THI1, indicating that the function as a sulfur donor is conserved, but the
rate of donation reaction is somehow affected. Also, the bound compoundswere isolated from both proteins
and are present in different amounts in each protein. Unfolding studies presented differences in melting
temperatures and also in the concentration of guanidine at which half of the protein unfolds, thus showing
that THI1(A140V) has its conformational stability affected by the mutation. Hence, despite keeping its func-
tion in the early steps during the synthesis of TPP precursor, our studies have shown a decrease in the
THI1(A140V) stability, whichmight be slowing down the biological activity of themutant, and thus contrib-
uting to thiamin auxotrophy.
© 2014 Elsevier B.V. All rights reserved.
1. Introduction
Thiamine, also known as vitamin B1, is a water soluble vitamin es-
sential for all living organisms [1]. It was discovered in 1911 by Casimir
Funk, isolated in 1932 from yeast and synthesized in 1935 [2]. Though
occurring in all living cells, only prokaryotes and a few eukaryotes,
such as fungi and plants, are able to de novo synthesize thiamine [3,4].
Because thiamine-dependent enzymes are crucial for central metabolic
pathways, changes in thiamine regulation can affect many different
processes. Thiamine deﬁciency has been linked to several neurological
disturbances, which are manifested in humans as beriberi and
Wernicke's encephalopathy [5].
Prokaryotes and eukaryotes use different strategies for the produc-
tion of thiamine [6]. Its biosynthesis involves the separate syntheses of
the thiazole and pyrimidine moieties, which are subsequently coupled.
Two biosynthetic routes for the thiazole have been identiﬁed [6,7]. The
mechanism of thiazole biosynthesis in prokaryotes is relatively well
understood and requires ﬁve proteins to catalyze the assembly of the
thiazole by a complex oxidative condensation of 1-deoxy-D-xylulose-
5-phosphate, glycine, and cysteine [8–11]. In eukaryotes, a different
pathway leads to the formation of the thiamine-thiazole and involves
a single gene product, so-called thiazole synthase: THI1 in Arabidopsis
thaliana and THI4 in Saccharomyces cerevisiae [10,12,13]. However, the
early steps of thiazole synthesis in eukaryotes are far from being satis-
factorily understood. The detailed mechanism of this pathway has
only begun to emerge [8,12].
Many intermediates of the thiamine pathway are predicted by
extrapolations from the characteristics of the prokaryotic thiamine bio-
synthesis[14]. Labeling studies in S. cerevisiae have demonstrated that
the thiamine-thiazole is synthesized from an unidentiﬁed ﬁve-carbon
carbohydrate, glycine, and cysteine [12]. This biosynthesis has not
yet been reproduced in vitro, but a metabolomic study has recently
proposed NAD+ (nicotinamide adenine dinucleotide) as the early
source of a ﬁve-carbon carbohydrate and the advanced intermediate
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as an ADP adduct of 5-(2-hydroxyethyl)-4-methylthiazole-2-carboxylic
acid [4,14].
The gene encoding THI1 protein was originally cloned due to its
capacity to complement Escherichia coli mutant line BW535 (xth,
nfo and nth genes), which is defective in DNA base excision repair
pathways [13]. THI1 homologues are the only known enzymes to
take part in the thiazole biosynthesis in a diversity of unicellular
organisms belonging to Archaea as well as multicellular organisms
[7].
In 2006 the THI1 structurewas solved,making it one of the fewplant
enzymes involved in thiamine biosynthesis whose 3D structure is
known [10,15]. THI1 is a homooctameric protein arranged as a tetramer
of dimers. The octamer is tightly packed as a two-layer ring torus struc-
tured by the arrangement of four dimers. The crystal packing reveals an
asymmetric unit containing twomonomers, which are kept together by
hydrogen bonds and hydrophobic contacts [10].
THI1 contains the characteristic GxGxxG signature (Gly46-Ala47-
Gly48-Ser49-Ala50-Gly51), a typical feature of the dinucleotide binding
protein family [10]. Its overall folding is similar to the dinucleotide bind-
ing domains with a higher similarity to FAD binding enzymes. Never-
theless several studies suggest that THI1 binds NAD+, whereas FAD
binding remains unknown [10,14]. THI1 shares some structural similar-
ity with an orthologue from Bacillus subtilis, ThiO, a FAD-dependent en-
zyme required for the thiazole biosynthesis, showing a well conserved
dinucleotide binding architecture [10].
The crystal structure of THI1 showed clear electron density for a
previously undescribed metabolite identiﬁed as adenosine
diphospho-5-(β-ethyl)-4-methylthiazole-2-carboxylic acid (ADT)
in the active site [7,10,12]. The crystal structure of THI1 contribut-
ed to the identiﬁcation of the thiamine intermediate and sub-
strates, which for many years remained elusive. However, the
exact biological role of THI1 during the thiazole-thiamine biosyn-
theses remains unknown.
For a long time the source of the thiazole sulfur remained unclear.
Recently, Chatterjee et al. [16] showed that THI4 acts directly on the
mechanism of thiazole formation. In an unusual reaction, THI4 uses
itself as a sulﬁde donor for thiazole formation, undergoing only a
single turnover during thiamine precursor biosynthesis [16,17]. Based
on experimental evidences with THI4, Chatterjee et al. reanalyzed the
electron density maps of THI4 and THI1 and observed no electron
density for Cys205 in THI4 and for Cys172 in THI1. In the latter, the Cα
is clearly planar showing a dehydroalanine (DHA) instead of the Cys
residue [16].
In A. thaliana, many thiamine-requiring mutant lines have been iso-
lated [18]. Two of these lines attracted particular interest, since without
thiamine supplementation the plants of the py line (mutations occur-
ring in the loci py, chromosome II) and the tz line (mutations occurring
in the loci tz, chromosome V, to which thiazole synthesis is attributed)
die early during development [18,19]. Papini-Terzi et al. [18] sequenced
the genomic thi1 fragments from two wild-type A. thaliana lines
(Columbia and Landsberg erecta) and from a tz-201 mutant. The analy-
ses of those sequences revealed a single-nucleotide change (C to T) be-
tween these ecotypes, driving an amino acid exchange, from alanine to
valine. Thismissensemutation at the position 140 (Ala→Val) is located
in a highly conserved region among eukaryotic THI1 homologues and
has been suggested as the cause of the thiamine auxotrophy observed
in this mutant plant line [18].
In this paper, we report a comparative biophysical study between
THI1 from A. thaliana and THI1(A140V) from A. thaliana tz-201 line.
Our goal is to evaluate the effect of this point mutation on the overall
structure and on its biological activity. Additionally, intending to
validate the proposition about the sulfur source during the thiazole bio-
synthesis [16] and to check the effect of the amino acid substitution on
this process, we carried out a cysteine quantiﬁcation using electron spin
resonance and a structural characterization of the ligands using
biochemical and spectroscopic methods.
2. Materials and methods
2.1. Cloning and protein production
2.1.1. Constructs
DNA sequences encoding truncated forms of THI1 or THI1(A140V)
(Supplementary information, Figure S1) were ampliﬁed by PCR with
the following primers: ThiS-NdeI forward (5′-GGATTTGCATATGTACGA
CTTGAACGCTTTCAC-3′) and ThiR-EcoRI reverse (5′-CGGAATTCTTATCA
GAGAGTTCCGTCAATAGC-3′) based on a sequence available with
accession number NC_003076. The thi1 or thi1(a140v) sequence was
subcloned in pET29a expression vector (Novagen, Inc., WI, USA) in
BamHI and EcoRI sites. The resulting plasmids were used for the trans-
formation of E. coli BL21(DE3) expression cell line. The constructs
were checked by dideoxy chain termination sequence method using an
ABI Prism 377 automated DNA sequencer (Perkin Elmer, CA, USA) fol-
lowing the manufacturer's protocol [20]. E. coli BL21(DE3) hosting the
recombinant plasmid pET29THI1 or pET29THI1(A140V) was grown in
Luria-Bertani (LB) medium containing kanamycin (30 μg/mL) with
shaking at 37 °C until the OD600 reached 0.8. The recombinant expres-
sion was induced by adding isopropyl-β-D-thiogalactopyranoside
(IPTG), at 0.4 mM ﬁnal concentration, and cell growth continued at
37 °C for 3 h. The cells were then harvested by centrifugation and the
resulting cell pellets were stored at−20 °C. Cells from 1 L culture were
resuspended in 20 mL of 20 mM Tris buffer pH 8.0, containing 150 mM
NaCl. The culture was lysed using sonication and the insoluble cell parti-
cles were separated by centrifugation at 14,000 ×g, for 25 min at 4 °C.
2.1.2. Site directed mutagenesis
Intending to check the loss of sulfur from Cys172, we ordered two
new mutants from Mutagenex Inc. (Hillsborough, NJ, USA), one for
THI1 and one for THI1(A140V). In both, we replace the Cys172 to Ser.
The newmutants were named THI1(C172S) and THI1(A140V)(C172V).
2.2. Protein puriﬁcation
Protein puriﬁcation was performed in two steps. The ﬁrst one was a
classical ammonium sulfate precipitation [21]. The proteins were pre-
puriﬁed in a 25% saturated (NH4)2SO4 solution containing 20 mM Tris,
pH 8.0. The protein and (NH4)2SO4 solutionswere kept under gentle ag-
itation for 45min. After incubation, the pre-puriﬁed proteins were sep-
arated by centrifugation at 20,000 ×g for 10 min at 4 °C. SDS-PAGE
under reducing conditions was carried out according to Laemmli using
15% gels [22]. The bands were stained with Coomassie Brilliant Blue.
The best (NH4)2SO4-saturation percentage was determined and
checked by 15% SDS-PAGE. The pellets containing pre-puriﬁed proteins
were resuspended in a 20 mM Tris, 150 mM NaCl, pH 8.0 and 1 mM
EDTA (resuspension buffer), and dialyzed extensively against the
resuspension buffer. The pre-puriﬁed proteins were loaded onto a
Superdex-200 HR 10/30 column (GE Healthcare) pre-equilibrated in a
resuspension buffer. Eluted fractions corresponding to puriﬁed proteins
(~30 kDa) were pooled. The chromatography was performed on ÄKTA
Puriﬁer (GE Healthcare), with a rate of 0.5 mL·min−1. The eluted
proteins were checked by 15% SDS-PAGE.
2.3. Protein concentration
The concentration of recombinant proteins was determined by UV
absorbance at λ= 280 nm (spectrophotometer U-2001 Hitachi) using
a theoretical extinction coefﬁcient based on the amino-acid composi-
tion. The theoretical extinction coefﬁcient employed was ε280 =
19.940 M−1·cm−1, calculated by ProtParam tool available on ExPASy
sever (Expert Protein Analysis System, http://ca.expasy.org/tools/
protparam.html) [23].
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2.4. Oligomerization state
2.4.1. Size exclusion chromatography
25 μM of pure THI1 or THI1(A140V) was loaded through a 500 μL
sample loop onto a Superdex 200 HR 10/30 size exclusion column
pre-equilibrated with 20 mM Tris, 150 mM NaCl, pH 8.0. Separation
was performed at a ﬂow rate of 0.5 mL·min−1. The column was
pre-calibrated with a low/high molecular weight calibration kit
(GE Healthcare) in order to estimate the oligomerization state of
THI1 or THI1(A140V), by comparing the elution volumes with the
calibration standards. The relative elution volume was calculated
as: Kav = (Ve − V0) / (Vc − V0), where Ve is elution volume, V0 is
the void volume, and Vg is the geometric column volume. A standard
curve of Kav versus log(M) was plotted. The apparent molecular weight
(MW) and the Stokes radius (Rs) of THI1 and THI1(A140V) were esti-
mated by a linear ﬁt of the Stokes radii of the standard proteins versus
the partition coefﬁcient Kav. The highmolecularweight (HMW)Calibra-
tion Kit (GE Healthcare) of standard proteins with known MW and Rs
was used. This calibration kit is composed by: aprotinin (MW:
6500 Da; Rs: not available), RNAse A (MW: 13,700 Da; Rs: 1.64 nm),
carbonic anhydrase (MW: 29,000 Da; 2.30 nm), ovalbumin (MW:
44,000 Da; Rs: 3.05 nm), conalbumin (MW: 75,000 Da, Rs: 3.64 nm),
aldolase (MW: 158,000 Da; Rs: 4.81 nm), ferritin (MW: 440,000 Da;
Rs: 6.10 nm), and dextran blue 2000 (~2,000,000 Da).
2.4.2. Native PAGE
Nondenaturant polyacrylamide gel electrophoresiswas performed on
a PhastSystem™ Electrophoresis System (GE Healthcare) using
PhastGel™ gradient 8–25 gels. 60 μM solution of THI1 and THI1(A140V)
was used and electrophoresis was carried out at a constant current over
a period of 40min according to instructions provided by themanufactur-
er. Proteins were visualized by Coomassie Blue staining.
2.4.3. Nondenaturant mass spectrometry
Prior to mass spectrometry (MS) experiments the proteins were
prepared under nondenaturant conditions; nonvolatile salts were
removed by exchanging the puriﬁcation buffer of samples to ammoni-
um acetate buffer 10 mM (pH 7.0) using a HiTrap™ Desalting
(Ge Healthcare) on ÄKTA Puriﬁer (GE Healthcare), at a ﬂow rate of
2 mL·min−1. After the buffer exchange, the samples were acidiﬁed
with 1% formic acid [24].
Electrospray ionization mass spectrometry experiments were car-
ried out using a micrOTOF (Bruker Daltonik, Bremen, Germany) mass
spectrometrer and multiple charged states were determined using the
ruler tool provided with a data analysis software compass micrOTOF
Bruker Daltonics. Samples were continuously sprayed at a ﬂow rate of
500 μL·h−1, with a nitrogen pressure of 2 bar. The end plate voltage
offset as set in the value of −400 V and the capillary at −4 kV. The
dry gas (N2) used for the desolvation process in the mass spectrometer
was heated at 300 °C with a ﬂow of 6 L·min−1. Molecular mass of pro-
tein or protein complexeswas calculated by averaging the value obtain-
ed from each charged state.
2.5. Electron spin resonance (ESR)measurements and spin labeling of THI1,
THI1(A140V), THI1(C172S) and THI1(A140V)(C172S)
Puriﬁed proteins were submitted to denaturation in 20mM Tris buff-
er (pH 8.0), containing 0.02MNaCl, 8Murea, and1mMDTT for 1h in ice
bath. Then, proteins were passed through a 5 mL HiTrap Desalting col-
umn (GE Healthcare, Uppsala, Sweden) equilibrated with labeling buffer
(20 mM phosphate, 0.02 M NaCl, 8 M urea, pH 8.0), and immediately
reacted with a 10-fold molar excess of the spin probe (1-oxyl-2,2,5,5-
tetramethyl-Δ3-pyrroline-3-methyl) methanethiosulfonate (MTSSL).
Labeling reactions were allowed to proceed for 4 h at room temperature
under gentle stirring. The proteins were concentrated to 300–400 μM
(9–12 mg·mL−1) in an Amicon® Ultra-15 concentrator ﬁtted with
Ultracel-10 membrane (Merck Millipore, Billerica, MA, USA). Excess
spin label was removed using the same desalting column eluted
with the labeling buffer (20 mM phosphate, 0.02 M NaCl, 8 M urea,
pH 8.0).
Continuouswave ESR spectroscopywas carried out at room temper-
ature (22 ± 1 °C) on a Varian E109 spectrometer operating at X-band
(9.4 GHz). Solutions containing denatured spin-labeled proteins were
drawn into capillary tubes for ESR experiments. Acquisition conditions
were: modulation amplitude, 0.5 G; modulation frequency, 100 kHz;
ﬁeld range, 100 G; incident microwave power, 5 mW and 2 scans. The
area of the doubly integrated spectra was calculated and compared to
the area obtained at the exact same conditions from the spectrum of
120 μM TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl)
standard.
2.6. Fluorescence
2.6.1. Steady-state ﬂuorescence
The ﬂuorescence emission measurements were performed on a
spectroﬂuorimeter (ISS, IL, USA), model ISS K2, equipped with a refrig-
erated circulator (Neslab RTE-210). The excitation and emission mono-
chromators were set at 2 and 1 nm slit widths, respectively. The
excitation wavelength was 295 nm and emission was registered in the
range of 300–450 nm. THI1 and THI1(A140V) concentrations in all
cases were 3 μM. Fluorescence data were obtained in the ratio mode
making use of the reference cell quantum counter. Corrections
were made for the signal from the appropriate blank and for the
wavelength-dependent bias of the optical and detection systems.
2.6.2. Stern–Volmer quenching
Quenching experiments were performed using excitation at 295
nm with ﬂuorescence and emission spectra recorded between 300
and 450 nm. Acrylamide quenching of tryptophan ﬂuorescence was
carried out by measurement of ﬂuorescence intensity after addition
of a series of small aliquots of freshly prepared acrylamide solution
(2M) to a sample drawn in a cuvette followed bymixing and incuba-
tion for 25 min in the sample compartment in the dark. The protein
concentration in all experiments was 3 μM. The ﬂuorescence intensi-
ties obtained were corrected for dilution. Quenching results were
plotted as the ratio of the ﬂuorescence intensity in the absence
of quencher (Fo) to the intensity in the presence of quencher (F) as
a function of quencher concentration. The linear region of the
quenching curves was ﬁt to themodiﬁed Stern–Volmer equation [25,
26]:
F0=F ¼ 1þ kqτ0 Q½  ¼ 1þ KSV Q½ ;
where [Q] is the molar quencher concentration and kqτ0 is equal to
KSV, the Stern–Volmer quenching constant [27].
2.7. UV circular dichroism (CD)
CD experimentswere carried out on a JASCO J-815 instrument (JASCO
Corporation, Japan) equippedwith Peltier thermostatting cuvette holder,
under constant nitrogen ﬂow. For far-UV region (190–250 nm), a 1-mm
path rectangular cuvettewas used andprotein concentrationswere 8 μM,
whereas a 10-mm path cuvette was employed for near-UV region
(250–300 nm), with protein concentration of 100 μM.
Final far-UV CD spectra were the average of 8 accumulations, using a
scanning speed of 100 nm·min−1, spectral bandwidth of 1 nm, and a
response time of 0.5 s. The solvent contribution was subtracted from
all experiments to eliminate background effects. All spectra were
smoothed with Fast Fourier Transform ﬁlter and converted to mean
residue ellipticity:
θ½ MRE ¼ θobs  0; l MRMð Þð Þ  c  lð Þ−1;
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where MRM is the mean residue molar mass, θobs is the ellipticity mea-
sured atwavelength λ, l is the optical path length of the cell, and c is the
protein concentration (mg·mL−1) [28]. The experiments were carried
out in triplicate.
2.7.1. Chemical and thermal unfolding
Chemical denaturation curves were taken in 20 mM Tris, 150 mM
NaCl, pH 8.0 and increasing concentration of guanidine hydrochloride
(GndHCl) from 0 to 1 M. The temperature of all experiments was
maintained at 22 °C unless otherwise indicated. Chemical unfolding
transitions were built by measuring the ellipticity changes at 222 nm
induced by the increase of guanidine concentrations. Thermal
unfolding transitions were monitored by taking the CD intensity at
222 nm as a function of temperature, from 20 to 86 °C at a heating
rate of 20 °C·h−1. Data processing was performed with the software
OriginPro8.
2.7.2. Data analyses
The denaturation curves contain the ellipticity changes at 222 nm of
THI1 and THI1(A140V) CD spectra as a function of either denaturant
concentration or temperature. The reversibility of the unfolding reac-
tion was checked by measuring the CD ellipticity at 20 °C after heating
until 86 °C. As the CD ellipticity was not recovered after cooling back,
a two-state irreversible unfolding mechanism was assumed.
Numerical data analysis of the THI1 and THI1(A140V) thermal
unfolding process was based on the two-state Lumry–Eyring model of
unfolding [29,30]. The ellipticity measured by CD spectroscopy was
analyzed assuming that this is an irreversible two-state process:
N→
k
U;
where N is the native state, U is the unfolded state, and k is a ﬁrst-order
kinetic constant, which changes with temperature according to the
Arrhenius equation. The data was analyzed as described by Sanchez-
Ruiz et al. [30].
Fraction of unfolded protein (fu) was calculated using the following
equation
f u ¼
θn−θobs
θn−θu
and f n þ f u ¼ 1;
where θn is the ellipticity of completely folded or native protein, θobs is
the observed ellipticity at any point of denaturant concentration or tem-
perature, and θu is ellipticity of the completely denatured or unfolded
protein [31].
The activation energy of the kinetic process and the apparent transi-
tion temperature (Tm) can be calculated from the Arrhenius plot. Ac-
cording to this kinetic model, the dependence of fn on the temperature
should follow:
ln ln
1
f n
  
¼ Ea
R
 
1
Tm
− 1
T
 
;
in which slope gives the value of the energy of activation (Ea) [32].
2.8. THI1 and THI1(A140V) ligand puriﬁcation and analyses
Approximately 30 mg of puriﬁed enzymes (THI1 or THI1(A140V))
was denatured by heating (100 °C, 5min) to release the ligands. The pre-
cipitated enzymes were removed by centrifugation at 16,000 ×g for
10min and the supernatant was ﬁltered through a 10 kDMW cut-off ﬁl-
ter (Amicon®Ultra-15 concentrator,MerckMillipore, Billerica,MA,USA).
2.8.1. HPLC analyses of ligands
100 μL of the ﬁltrate bound small molecules was analyzed by reverse
phaseHPLC (C18 column,Waters, 25 cm×4.6mm, 6 μm). The following
gradient was used at 1 mL·min−1 ﬂow rate: solvent A is water, solvent
B is 100mMKPi, pH 6.6, solvent C isMethanol; 0min 100% B; 5min 10%
A and90% B; 8min 25%A, 60% B and 15%C; 14min 25%A, 60% B and 15%
C; 19 min 30% A, 40% B and 30% C; 21 min 100% B; 30 min 100% B [14].
The absorbance at 258 nm was monitored.
2.8.2. UV spectra analyses of ligands
The UV–visible spectra of the bound small molecules from THI1 and
THI1(A140V) were analyzed in a Hitachi U-2001 spectrophotometer
(Tokyo, Japan), from 400 to 230 nm at 400 nm·min−1, whereas a
10-mm path cuvette was used.
2.8.3. Near-UV CD analyses of ligands
These experiments were carried out on a JASCO J-815 instrument
(JASCO Corporation, Japan), from 350 to 250 nm, using a 5-mmpath cu-
vette. Final far-UV CD spectra were the average of 8 accumulations,
using a scanning speed of 100 nm·min−1, spectral bandwidth of
1 nm, and a response time of 0.5 s. The solvent contribution was
subtracted from all experiments to eliminate background effects.
2.8.4. NMR analysis of the ligands
The ligands were extracted from THI1 and THI1(A140V) as de-
scribed above and then frozen under liquid nitrogen and lyophilized.
For the NMR experiments the samples were dissolved in 500 μL D2O
containing 100 μM of DSS (4,4-dimethyl-4-silapentane-1-sulfonic
acid) for spectra referencing. 1H 1D NMR spectra were acquired in a
600 MHz Bruker AVANCE III spectrometer equipped with a 5 mm TCI
cryoprobe. A total of 32 scans have been performed; residual water
has been suppressed by presaturation. A sample of adenosine diphos-
phate (ADP), believed to be a precursor of ADT, was also measured as
a means to identify the ligands extracted from the proteins.
3. Results and discussion
3.1. Oligomerization state studies
One of the main problems that has puzzled many researchers is the
role of the thiazole biosynthetic enzyme THI1 in the thiamine biosyn-
thetic pathway [6]. THI1 high resolution crystal structure as well as
studies of THI1 in solution (size exclusion chromatography and dynam-
ic light scattering) showed that the quaternary structure of THI1 is com-
posed by eight monomeric subunits forming a homooctamer with a
molecular mass of 244 kDa and a hydrodynamic radius of 6.24 nm [10].
Due to the lack of information on the thiamine biosynthesis route in
eukaryotes, studies that can shed light on the role of THI1 function are
relevant and the A. thaliana tz-201 mutant line is very convenient in
this context. THI1 from this line has a natural point mutation in residue
140, which is responsible for the thiamine auxotrophy. This pointmuta-
tion is not in the active site of THI1, but it is on the surface of a small loop
between two β-sheets that is part of the subunit interface [18], which
could then disturb the THI1(A140V) oligomer.
In order to investigate the role of the point mutation on THI1 struc-
ture using biophysical methods for a structural comparison and cys
quantiﬁcation, THI1 and THI1(A140V) were overexpressed in E. coli.
The proteins were puriﬁed by ammonium sulfate precipitation
and size exclusion chromatography. The combination of these two
procedures ensured a good amount of pure protein: 40 mg of THI1
and 25 mg of THI1(A140V) per 1 l of culture.
To evaluate the integrity and oligomerization state of THI1(A140V)
as compared to THI1 we used three different techniques: native-PAGE,
size exclusion chromatography (SEC) and electrospray ionization
mass spectrometry. The apparent molecular masses of THI1 and
THI1(A140V) were ﬁrst determined by nondenaturant gel electropho-
resis (inset on the left of Fig. 1) and size exclusion chromatography.
The migration proﬁles on native PAGE of THI1 and THI1(A140V) were
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similar, indicating in both cases an apparentmolecularmass around the
expected value of 200 kDa.
Fig. 1 also shows the size exclusion chromatography elution proﬁle
of THI1 and THI1(A140V) indicating an apparent molecular mass of
191 kDa for THI1 and 203 kDa for THI1(A140V). The Stokes radius
(Rs) calculated for THI1 is 4.9 nm and for THI1(A140V) 5.1 nm. Our
native-PAGE and SEC results showed that THI1 and its natural mutant
apparently have the same oligomeric state.
ESI was used to conﬁrm with higher accuracy the molecular masses
of THI1 and THI(A140V). Mass spectra for THI1 and THI1(A140V) in
100% aqueous conditions, 10 mM ammonium acetate, pH 7 are shown
in Supplementary information, Figure S2. Four charge states, from
+35 to +32, for THI1 and ﬁve states, from +35 to +31 for
THI1(A140V), were observed over the mass range of m/z 6500–8000.
The deconvolution of each protein spectrum results in the average
masses of 241.94 kDa for THI1 and 242.29 kDa for THI1(A140V),
which are in good agreement with the theoretical average masses of
an homooctameric conformation. The slight differences in charge-state
distribution between THI1 and THI1(A140V) are probably due to a
small conformational change induced by the point mutation [33,34].
The existence of ﬁve protonated states for THI1(A140V) instead of
four protonated states for THI1 suggests that the overall conformation
of THI1(A140V) is slightly less compact. The results reported here clear-
ly demonstrate that the natural point mutation in the position 140 has
no signiﬁcant effect on the THI1 quaternary structure.
3.2. Electron spin resonance (ESR) measurements
The results presented so far were focused on the role of the natural
point mutation on the THI1 oligomerization process, which indicated
no differences in the quaternary organization of THI1(A140V) when
compared to THI1. However, the point mutation could still affect
THI1(A140V) biological activity. All that is known about THI1(A140V)
activity comes from in vivo analysis of A. thaliana Tz-201 line. The plants
of this line grow up until the adult age only if there is a thiazole or thi-
amine supplementation [18]. Recently, Chatterjee et al. [16] published
a very elegant work, where they proposed an unusual catalytic mecha-
nism for THI4 and extended this conclusion for THI1. The authors
proposed that THI4 uses itself as a sulfur donor for thiazole formation
and undergoes only a single turnover in a suicide mechanism using
NAD+ as a precursor [16].
In the absence of a standard biological activity assay, we used elec-
tron spin resonance (ESR) to check the sulfur donation proposition for
THI1 and THI1(A140V), and additionally intending to conﬁrm the loss
of the sulfur atom from Cys172, we performed a control experiment
with mutants THI1(C172S) and THI1(A140V)(C172S), where the
Cys172 was replaced by a Ser residue. ESR of selectively placed
spin labels allows directly probing the local environment and struc-
ture of individual residues [35–37]. More speciﬁcally, we spin la-
beled cysteine residues in either THI1, THI1(A140V), THI1(C172S)
or THI1(A140V)(C172S) to quantify the number of cysteines and
check for the presence of Cys172 in the THI1 and THI1(A140V) (Supple-
mentary information, Figure S3), thus having indirect information on
the protein biological activity.
Fig. 2 shows the ESR spectra from the TEMPOL spin label in solution
and from labeled proteins. The double integration of those spectra led to
the area values in Table 1. The area of the doubly-integrated spectrumof
TEMPOL in solution and its known concentrations determine the stan-
dards for estimation of other protein concentrations from the areas of
each doubly-integrated ESR spectrum. As reported by Chatterjee et al.
[16] for THI4 in S. cerevisiae, THI1 in A. thaliana act as the thiazole sulfur
atom source. In other words, the donor protein is therefore functioning
as a reagent rather than as a conventional catalytic enzyme. The results
from ESR experiments (Fig. 2) revealed that THI1 acts in the same way,
since the Cys quantiﬁcation showed in Table 1 gives just one Cys residue
per monomer. THI1 probably loses a sulfur atom from its Cys172 side
chain during biosynthesis converting Cys172 to a dehydroalanine
(DHA) residue. The Cys quantiﬁcation for THI1(A140V) indicates that
the same catalytic process is happening, but based on the results, not
all Cys172 seems to lose the sulfur atom. This result suggests that the
catalytic activity is preserved in THI1(A140V), but the rate of sulfur do-
nation might be affected by the substitution of Ala140 to Val becoming
slower when compared to the same process in THI1. The quantiﬁcation
of Cys residues for the two control mutants, THI1(C172S) and
THI1(A140V)(C172S), showed that there is, as expected, one Cys
residue per monomer.
Fig. 1. THI1 and THI1(A140V) oligomerization states. Analytical size exclusion chromatography of THI1 (solid line) and THI1(A140V) (dashed line). The THI1 and THI1(A140V) chromato-
graphic proﬁles show the same behavior for both proteins. The apparent molecular mass calculated as described in experimental procedures indicated an octameric state for THI1 and
THI1(A140V). The proteins were eluted in 20 mM Tris buffer pH 8.0, containing 150 mM NaCl, as homogeneous species at the same elution volumes (Ve) using an analytical Superdex
200 10/30 column. One of the insets shows the linear ﬁt of known Stokes radii (Rs) as a function of the measured partition coefﬁcient (Kav). The calculated Rs for THI1 and
THI1(A140V) were very similar. The other inset shows a native-PAGE of THI1 and THI1(A140V) proteins in lanes 1 and 2, respectively. MM lane corresponds to the molecular mass
standards.
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3.3. The inﬂuence of point mutation on tertiary contacts
THI1 is a protein rich in aromatic groups. Each monomer has 8
phenylalanine, 6 tyrosine and 2 tryptophan residues. Apart from these
residues it is known that THI1 is copuriﬁed with a metabolite identiﬁed
as ADT,which is formed by two ring regions, one of thembeing a pyrim-
idine portion and the other a thiazolic portion. These aromatic groups
were then used as intrinsic ﬂuorescent dyes to check the effect of
the A→ V mutation on the THI1 tertiary structure.
Despite having several phenylalanine and tyrosine residues, trypto-
phan by itself drives the ﬂuorescence emission due to its high quantum
yield. We used a photoselection excitation of Trp residues at 295 nm
[27]. Trp80 is located on THI1 hydrophobic core, in the neighborhood
of the ADT interaction site, and the other Trp residue (Trp160) is exactly
at the dimerization interface.
The ﬂuorescence emission spectra of THI1 and THI1(A140V) are
presented in Fig. 3. The main difference between them is the dramatic
increase in quantum yield for THI1. The THI1 ﬂuorescence intensity is
almost twice as large as that observed for THI1(A140V). This difference
may be attributed to chemical changes in the Trp neighborhood, since
the information provided by Trp ﬂuorescence is related to both the
exposition of this residue to the solvent and to its local mobility. As
discussed before, one of the Trp residues is very close to the hydropho-
bic core and the other one is in the dimerization interface, which shows
some hydrophobic residues. It is possible that the point mutation
induces some local structural changes, since it occurs in a loop (a very
packed region in the middle of the four octamer subunit), which may
affect the Trp160 microenvironment resulting in a decrease of
THI1(A140V) ﬂuorescence intensity, followed by a subtle red shift
(331 to 334 nm).
Although the emission ﬂuorescence experiments show a distinct be-
havior between THI1 and THI1(A140V), the slight red shift did not tell
enough about what is really happening in the Trp microenvironment.
To explore this furtherweused aﬂuorescence quenching assay to inves-
tigate the effect of the point mutation on the THI1 tertiary contacts. Ac-
rylamide quenching of tryptophan ﬂuorescence is a convenientmethod
for monitoring tryptophan environments in proteins. The inset in Fig. 3
shows the results obtained from the quenching experiments for THI1
and THI1(A140V) using acrylamide as suppressing agent. The slope
(KSV) of the Stern–Volmer plot is related to the degree of exposure or
accessibility of the tryptophan residues [38].
The linear Stern–Volmer plots were obtained for THI1 and
THI1(A140V), indicating the presence of a single class of ﬂuorophores
with equal accessibility to the quencher [39]. The KSV values for THI1
and THI1(A140V) were 1.5 ± 0.1 and 2.3 ± 0.2 M−1, respectively.
THI1(A140V) has the higher acrylamide accessibility, as indicated by a
Stern–Volmer constant (KSV) that is approximately 34% higher than
that of THI1. The increase in the KSV values reﬂects the exposure
degree of tryptophan residues. Molla et al. showed that KSV values for
soybean agglutinin in different quaternary organizations have a differ-
ent KSV, 2.2 M−1 for tetramer, 5.0 M−1 for monomer and 14.6 M−1 for
denatured form [38]. For a totally solvent-exposed Trp residue under
acrylamide suppression the KSV is 25 M−1 [27,40]. The differences in
KSV values show that somehow the natural point mutation changed
Fig. 2. ESR spectra of: free TEMPOL (top left), labeled THI1 (top right), labeled THI1(A140V) (middle left), labeled THI1(C172S) (middle left) and labeled THI1(A140V)(C172C)
(bottom left).
Table 1
Cys quantiﬁcation by ESR for THI1, THI1(A140V), THI1(C172S) and THI1(A140V)(C172S).
Tempol THI1 THI1
(A140V)
THI1
(C172S)
THI1
(A140V)(C172S)
Area 1.05 × 1013 2.75 × 1013 9.10 × 1013 4.70 × 1013 8.50 × 1013
Concentration (λ = 280 nm) (μM) – 277 667 519 898
Concentration (ESR) (μM) 120 313 1040 536 969
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the tertiary contacts making the quaternary structure more susceptible
to any change in the protein environment, which can lead to a loss of
overall THI1(A140V) stability when compared to the wild type protein.
To further check the effect of the point mutation on the overall
conformation of THI1, we also performed near-UV CD (350 to
250 nm) experiments. THI1 and THI1(A140V) near-UV CD spectra
(Fig. 4) showed remarkable differences in the band intensities, revealing
the presence of a wide peak in the region between 293 and 304 nm for
THI1. The Tyr and Trp bands are present in both spectra with the maxi-
mum usually related to these chromophers [41–43] between 278 and
286 nm for THI1 and between 279 and 286 nm for THI1(A140V). The
changes noticed in THI1(A140V) spectramay either result fromchanges
in the microenvironment of the aromatics residues or indicate a
rearrangement of the tertiary contacts induced by the point mutation.
Together the results provided by ﬂuorescence and near-UV CD
experiments support our assumption that the loop where the point
mutation occurs plays an important role in THI1 proper fold in a tertiary
level.
3.4. Far-UV circular dichroism (CD)
Our oligomerization studies revealed that the integrity of the
octameric structure is not affected by thepointmutation. Thus, that can-
not be the reason for thiamine auxotrophy in A. thaliana line tz-201. On
the other hand, the results provided by ﬂuorescence andnear-UVCD re-
vealed a remarkable inﬂuence of point mutation on tertiary contacts,
which probably can affect THI1 stability. To further investigate this
and to look for some inﬂuence of the point mutation on the protein
structure and stability, the integrity of the secondary structure was an-
alyzed by far-UV CD. The CD spectra for THI1 and THI1(A140V) (data
not showed) have the same shape with minima centered in 208 nm
(π→ π* transition) and 220 nm (n→ π* transition). The deconvolution
of the CD data using CDPro [44,45] software conﬁrmed that the point
mutation does not disturb THI1 secondary structures. The percentages
ofα-helix (34%) and β-sheet (23%) contents were the samewhen com-
pared to THI1 structure available on the protein data bank (PDB ID:
1RP0) [10].
To compare THI1 and THI1(A140V) structural stabilities, chemical
and thermal denaturation CD experiments were performed. Fig. 5A
shows the unfolding curves obtained by monitoring ellipticity values
at 220 nm as a function of a chaotropic agent concentration. The analy-
sis of the CD spectra reveals that THI1 and THI1(A140V) are very sensi-
tive to the presence of guanidinewith a decrease in ellipticity starting at
0.1 M of guanidine. The difference between the THI1 and THI1(A140V)
denaturation curves is clear: THI1 structure is more resistant to guani-
dine than THI1(A140V). The reversibility of the chemical unfolding
reactionwas tested and after extensive dialyses to remove the chemical
denaturant, the proteins were unable to restore the native conforma-
tion. Nevertheless, an indirect analysis was performed by doing a
sigmoid-like ﬁt to the denaturation curves, which allows calculating
guanidine critical concentration, where half proteins are folded and
the other half is in the unfolded state. The values obtained were 0.42
± 0.01 M for THI1 and 0.24 ± 0.05 M for THI1(A140V). This indicates
that the secondary structure of THI1 is more stable to guanidine
denaturation than THI1(A140V), clearly showing that the point muta-
tion affects the overall THI1 stability.
The thermal stabilities of THI1 and THI1(A140V) were also studied
using far-UV CD (Fig. 5B). The thermal denaturation proﬁles (Fig. 5B),
plotted as unfolded protein percentage as a function of the temperature,
start changing around 56 °C for THI1(A140V) and around 60 °C for
THI1, showing that the A140V mutation makes THI1 more susceptible
to temperature. The reversibility of the thermal unfoldingwas also test-
ed, and, as observed for the chemical unfolding, these reactionswere ir-
reversible. As expected for large proteins or protein complexes that
show multidomains or oligomers, such as THI1, aggregation can occur
as a side reaction that competes with proper folding. Thus, the irrevers-
ibility of the unfolding processes makes the calculation of equilibrium
thermodynamic parameters not feasible [46].
THI1 and THI1(A140V) denaturation curves show sigmoid-like pro-
ﬁles that can be described by a two-state irreversible model and allows
theuse of Arrhenius theory [31] to assess the activation energy and tem-
perature transition (Tm). Following the Lumry and Eyring model [47], a
plot of ln[ln(1/fn)] versus 1/T gives the activation energy as well as the
transition temperature. In our case, we obtained activation energy of
119 kJ·mol−1 for THI1 and 89 kJ·mol−1 for THI1(A140V). From the
linear coefﬁcients the transitions temperature were determined: Tm
was 350 K for THI1 and 346 K for THI1(A140V). The values found for
Ea and Tm show that the point mutation makes THI1(A140V) more
unstable than THI1.
To complement our experimental data, a bioinformatic analysis,
based on the algorithm CUPSAT, available at http://cupsat.tu-bs.de/,
was used. CUPSAT allows doing a stability prediction (ΔΔG) upon a
Fig. 3. Steady-state ﬂuorescence emission spectra of THI1 and THI1(A140V). Fluorescence
spectra of THI1 (solid line) and of THI1(A140V) (dashed line). The inset shows the Stern–
Volmer plots for the quenching of the Trp ﬂuorescence residues of THI1 (circles) and
THI1(A140V) (triangle) by acrylamide in an aqueous buffer. The ﬁnal concentrations of
proteins were 3 μM, in a total volume of 500 μL of 20 mM Tris buffer, 150 mM NaCl,
pH 8.0. The temperature was maintained at 25 °C.
Fig. 4.Near-UV CDof THI1 (solid line) and THI1(A140V) (dashed line). Themeasurements
were done in 20 mM Tris buffer, pH 8.0, containing 150 mM NaCl, at 25 °C. The protein
concentration used was 100 μM.
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pointmutation using structural, speciﬁc environment, atomic potentials
and torsion-angle potentials derived from the distribution of protein
backbone φ and ψ angles from two nonredundant protein structure
datasets, containing 1538 and 1603 mutants [48,49]. The prediction
model can distinguish the amino acid environment using its solvent ac-
cessibility and secondary structure speciﬁcity. It uses protein environ-
ment speciﬁc mean force potentials to predict the protein stability.
The negative and positive predicted ΔΔG values mean the destabilizing
and stabilizing effects, respectively. In case of unfavorable torsion
angles, the atom potentials may have higher impact on the stability of
protein, which results in destabilizing the system [50].
Table 2 shows the results provided by CUPSAT. The predicted energy
ΔΔG value shows that the point mutation A140V is destabilizing and it
is probably due to the unfavorable torsion angles and the atom poten-
tials. The result revealed that changing Ala to Val can lead to change
the overall stability of THI1.
The results from these analyses upon point substitutions in the
position 140 suggest that both thermal and chemical denaturations of
THI1 are highly affected by the change of alanine to valine, destabilizing
the overall THI1 structure. Thereby, the results from chemical and ther-
mal unfolding experiments and from the in silico analyses using CUPSAT
revealed that the pointmutation decreases THI1 stability and somehow
this apparent fragility may affect THI1 biological activity.
3.5. Looking for activity of THI1 and THI1(A140V)
All data presented so far indicates that the substitution of Ala140 to
Val, althoughmaintaining the protein quaternary arrangement, disturbs
the protein stability and changes THI1 proper fold in a tertiary level.
However, we had no evidence that this point mutation affects the pro-
tein activity. Toﬁll this gap, we ﬁrstly checked the ability of themutated
protein to produce the ADTmolecule identiﬁed before in THI1 3D struc-
ture [10] and believed to be involved in the protein catalysis. In the pro-
cess of searching for THI1(A140V) activity we performed a similar
experiment to that reported by Chatterjee et al. [14] for THI4 separating
the boundmolecules from THI1 and THI1(A140V) and performing their
structural characterization. Fig. 6 shows theHPLC analysis of co-puriﬁed
ligands. The elution proﬁle revealed the existence of four bound
compounds for both proteins, but the intensities of the peaks indicate
that these molecules are present in different amounts in each protein.
Toweigh up the contents of the ligands, we did a qualitative analysis
using UV and near-UV CD spectroscopies (Supplementary information,
Figure S4). The UV and near-UV CD of THI1(A140V) spectra revealed
different absorption bands and optical activity which can be explained
by differences in the composition and/or conformation between the
ligands from THI1 and THI1(A140V). Taken together, our results show
that THI1(A140V) is able to produce some ligands, and thus this protein
seems to maintain its biological activity.
To further evaluate the effect of the point mutation the ligands
extracted from the proteins were also submitted to high-resolution
NMR analyses. Fig. 7 shows a selected region from the 1H 1D NMR for
the ligands obtained from the wild-type THI1 and from the mutant
THI1(A140V) along with the spectrum for ADP, a molecule believed to
be a precursor of ADT. This last spectrum was used to help assigning
the peaks in the NMR spectra of the ligands obtained by extraction
from THI1 and THI1(A140V). The peaks arising from the pentose proton
(l, Supplementary information, Figure S5) and from two adenine pro-
tons (m and p, Supplementary information, Figure S5) of the ADT mol-
ecule could be assigned (Fig. 7) and conﬁrmed by using chemical shifts
previously published in the literature [8,11,14]. The spectra also showed
ADP peaks in both ligand samples (l′, m′, m″ and p′), indicating that
ADP is one of the compounds present in extracts from the proteins.
Table 2
Stability prediction for THI1 monomer under Ala to Val substitution in the position 140,
analyzed by the CUPSAT server.
Prediction for monomer Overall stability Torsion Predicted
ΔΔG(kcal/mol)
Thermal Destabilizing Unfavorable −0.43
Chemical Stabilizing Unfavorable 3.53
Fig. 6. Elution proﬁle analysis of THI1 (solid line) and THI1(A140V) (dashed line) bound
small molecules by HPLC using C18 (25 cm × 4.6 mm, 6 μm).
Fig. 5. Far-UV CD chemical and thermal unfolding. A) Chemical unfolding — denatured
protein fraction (D) as a function of GndHCl concentration. The inset shows the far-UV
CD scan of THI1(A140V) as function of GndHCl. The protein concentration was 8 μM, in
20 mM Tris pH 8.0 containing 150 mM NaCl, at 25 °C. GndHCl induced unfolding of
THI1 (circles) and THI1(A140V) (triangles) monitored by CD spectroscopy was irrevers-
ible. B) Thermal unfolding — THI1 (circles) and THI1(A140V) (triangles) denatured frac-
tions as a function of temperature. The solid lines represent the transition curves
calculated according to a sigmoid-like function. The inset shows the CD spectra of
THI1 at different temperatures and at pH 8.0.
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Assuming that ADP is transformed to ADT upon catalysis, a comparison
between the intensities of the peaks attributed to ADT and ADP in each
sample can be used to infer whether enzyme catalysis is taking place.
From the spectra in Fig. 7, we can then see that the ADT peaks in the
THI1 sample are more intense than the same peaks in the sample con-
taining the ligands extracted from THI1(A140V). Furthermore, the
peaks assigned to ADP are less intense in THI1 than in THI1(A140V).
Hence, the native protein THI1 is more efﬁcient in producing ADT mol-
ecules than THI1(A140V). However, it is worth noting that, although
less effective, THI1(A140V) is still capable of producing ADT, thus
indicating that the mutated enzyme retains some activity, which is
somehow slowed down, probably because of changes in the mutant
protein tertiary structure as indicated from our stability studies
presented above.
4. Conclusions
In a previous work, Papini-Terzi et al. presented a genetic and phe-
notype view about the role of point mutation A140V observed in THI1
from A. thaliana tz-201 line. In the presentwork, we used a series of bio-
physical and biochemical methods to further investigate the effects of
such point mutation in the overall THI1 structure, stability and activity.
In this way, THI1 and THI(A140V) proteins and their ligands, were
produced, puriﬁed and subjected to biophysical/biochemical analyses.
Several studies were performed to check the THI1(A140V) secondary
and quaternary structure integrity and all data showed that this protein
is very similar to THI1 in the structure content. However, tertiary
contacts showed signiﬁcant differences possibly induced by the point
mutation.Moreover, the structural stability experiments indicate differ-
ences between THI1 and THI1(A140V), with melting temperatures
differing of ca. 4 °C and in critical GndHCl concentration of ca. 0.2 M.
All data presented here indicates that the substitution of Ala140 to
Val disturbs protein stability and changes protein proper fold in a tertia-
ry level. Looking for some evidence that this point mutation changes
the proteins activity, THI1 and THI1(A140V) activities were indirectly
checked by Cys spin-labeled approach using ESR spectroscopy. The
goal here was to determine whether the sulfur group of Cys172 existed
in both proteins and our ESR results showed that THI1 as well as
THI1(A140V) are able to donate a sulfur to the synthesis of the thiazole.
Additionally, we check the ability of mutated protein to produce
the ADT molecule isolating the bound molecules from THI1 and
THI1(A140V), as reported before by Smith et al. [15] for THI4. Our
analysis reveals the existence of different bound compounds, for both
proteins, but these molecules are present in different proportions in
each protein. Analysis of these proportions indicates that the native
protein THI1 is more efﬁcient than THI1(A140V) in producing ADT
molecules.
Based on the tz-201mutant line phenotype togetherwith our obser-
vations regarding THI1 and THI1(A140V) catalytic activity, we propose
that changes on the tertiary contacts and on the overall THI1 structure,
induced by the point mutation, directly affect the rate of the thiazole
biosynthesis.
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